Viewing StudyNCT05216237



Ignite Creation Date: 2024-05-06 @ 5:09 PM
Last Modification Date: 2024-10-26 @ 2:23 PM
Study NCT ID: NCT05216237
Status: RECRUITING
Last Update Posted: 2022-04-11
First Post: 2022-01-19

Brief Title: A Study to Evaluate the Efficacy and Safety of Sintilimab Plus Apatinib and Chemotherapy in Patients With HER-2 Negative Microsatellite Stability MSS Advanced or Metastatic Gastric GC or Gastroesophageal Junction GEJ Cancer
Sponsor:
Organization: Affiliated Hospital of Qinghai University